Haina Pharma is committed to building a comprehensive pharmaceutical enterprise integrating R&D, production and sales, and provides partners with new drugs from drug discovery, research, registration, clinical, API production, intermediate manufacturing, formulation production and packaging. Develop full-process services and integrated solutions. Recently, Jincai Investment Management Fund completed a new round of financing for Haina Pharmaceuticals. The scale of this financing is 100 million yuan, and the overall valuation after the investment reaches 1.58 billion yuan. Funds are mainly used for clinical cost investment, the company’s R&D pipeline layout, R&D talent echelon construction and clinical business expansion.
This article is reproduced from: https://www.itjuzi.com/investevent/13476440
This site is for inclusion only, and the copyright belongs to the original author.